Ecopipam (SCH-39166) is a synthetic benzazepine derivative drug that acts as a selective dopamine D1/D5 receptor antagonist with little affinity for either dopamine D2-like or 5-HT2 receptors. It has sedative antipsychotic and anorectic effects and was researched for human use although never approved for medical prescription mainly because of side effects such as depression and anxiety.
This page contains content from the copyrighted Wikipedia article "Ecopipam"; that content is used under the GNU Free Documentation License (GFDL). You may redistribute it, verbatim or modified, providing that you comply with the terms of the GFDL.
